Results 1-8 of 8 (Search time: 0.006 seconds).

Issue DateTitleAuthor(s)SourcescopusWOSFulltext/Archive link
12008Association of galactose single-point test levels and phenytoin metabolic polymorphisms with gingival hyperplasia in patients receiving long-term phenytoin therapyHorng-Huei Liou; CHUN-JUNG LIN Pharmacotherapy 76
22016Comparative Cardiovascular and Cerebrovascular Safety of Inhaled Long-Acting Bronchodilators in Patients with Chronic Obstructive Pulmonary Disease: A Population-Based Cohort StudyCHIA-LIN HSU; Dong, Yaa-Hui; Chang, Chia-Hsuin; CHIA-HSUIN CHANG; Gagne, Joshua J.; Hsu, Chia-Lin; Lai, Mei-ShuPharmacotherapy 129
32008Comparison of drug adherence rates among patients with seven different medical conditionsKin-Wei Chan Pharmacotherapy 351346
42011Effect of Helicobacter pylori eradication therapy on risk of hospitalization for a major ulcer eventFEI-YUAN HSIAO Pharmacotherapy 710
52005Effects of calcineurin inhibitors on sirolimus pharmacokinetics during staggered administration in renal transplant recipientsPO-HUANG LEE; MENG-KUN TSAI; REY-HENG HU; FE-LIN LIN WU ; TSAI, MENG-KUNG; CHEN, RUSSEL RHEI-LONG; SUN, SHAO-WEN; HUANG, JIN-DING; LEE, PO-HUANGPharmacotherapy 2628
62011Focal segmental glomerulosclerosis with acute renal failure associated with eltrombopag therapyHUEY-LING CHIANG Pharmacotherapy 10
72011Role of omeprazole dosage and cytochrome P450 2C19 genotype in patients receiving omeprazole-amoxicillin dual therapy for Helicobacter pylori eradicationCHUN-JUNG LIN ; JYH-CHIN YANG ; CHIA-TUNG SHUN; BOR-RU LIN Pharmacotherapy 3329
82003Time-dependent amplified pharmacokinetic and pharmacodynamic responses of rabeprazole in cytochrome P450 2C19 poor metabolizersCHUN-JUNG LIN ; JYH-CHIN YANG Pharmacotherapy 1916